The Export Control (Amendment) Order 2012

Type Statutory-Instrument
Publication 2012-03-23
State In force
Department Queen's Printer of Acts of Parliament
PDF Download
articles Not indexed
Reform history JSON API

Made: 23rd March 2012

Laid before Parliament: 26th March 2012

Coming into force: 16th April 2012

The Secretary of State, in exercise of the powers conferred by sections 1 and 5 of the Export Control Act 2002[^f00001], makes the following Order.

Citation and commencement

1

This Order may be cited as the Export Control (Amendment) Order 2012 and comes into force on 16th April 2012.

Revocation

2

The Export Control (Amendment) (No. 3) Order 2011[^f00002] is revoked.

Amendments to the Export Control Order 2008

3

(4A) (1) Subject to articles 17 and 26, no person shall export a human or veterinary medicinal product containing the active ingredient pancuronium bromide where— (a) the product is in a form suitable for injection or for preparation of an injection; and (b) paragraph (2) or (3) applies. (2) This paragraph applies where the destination of the product is the United States of America. (3) This paragraph applies where the destination is not the United States of America but the exporter knows that the final destination of the product is the United States of America.

Signed

David Willetts — Minister of State for Universities and Science — Department for Business, Innovation and Skills — 23rd March 2012

Explanatory note

(This note is not part of the Order)

EXPLANATORY NOTE

This Order amends the Export Control Order 2008 (S.I. 2008/3231) to insert article 4A to prohibit the export of human and veterinary medicinal products containing pancuronium bromide. The prohibition only applies to the export of these products where they are in a form suitable for injection or for preparation of an injection and the final destination is the United States of America.

It also revokes the Export Control (Amendment) (No.3) Order 2011 (S.I. 2011/1127) which is spent.

A regulatory impact assessment has not been prepared for this instrument as it has no or minimal impact on business, charities or voluntary bodies. An Explanatory Memorandum is published alongside the instrument on www.legislation.gov.uk.

Footnotes

[^f00001]: 2002 c. 28.

[^f00002]: type=start slip=2012-08-01 time=1345124746406S.I. 2011/1127type=end slip=2012-08-01 time=1345124746406.

[^f00003]: S.I.2008/3231; relevant amending instrument is type=start slip=2012-08-01 time=1345124765328S.I. 2011/1127type=end slip=2012-08-01 time=1345124765328.

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.

This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence. legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.